Off your game?
Read our free, updated as of Mar 3, 2022, Dr K report on how to optimize your mind and body so you can boost your focus when trading the markets.
Meet Dr K !
Chris Kacher
  • Nuclear physicist
  • Stock & crypto market wizard
  • Blockchain builder
  • Bestselling author
  • Top 40 charted musician
  • Biohacker
  • Former computer hacker
Your email will always remain private.

MLR - PMP 6/18/14

Major averages rose yesterday on higher volume with the risk-on small cap Russell 2000 up the most. The Fed's two-day meeting concludes today though the Fed is expected to keep the QE-pump flowing as interest rates aren't expected to rise until mid-2015 at the very earliest, though any hike could be delayed well into 2016 given how ineffective QE has been to jump start economies domestically and internationally.

Market internals remain strong as a number of constructive buy points continue to pop up.

Pocket pivots:

Chinese internet security software provider Qihoo 360 Technology (QIHU) had a pocket pivot yesterday coming up through its 200-day moving average. Earnings and sales are skyrocketing, pretax margin 37.4%, ROE 37.3%, group rank 54.

Clothing and accessories retailer Kate Spade (KATE) had a pocket pivot yesterday within the handle of a cup-with-handle base. Institutional sponsorship has grown 5 quarters in a row, group rank 72.

Therapeutics developer Horizon Pharmaceuticals (HZNP) had another pocket pivot within its base yesterday. Sales are soaring, institutional sponsorship has grown 11 quarters in a row since its IPO, group rank 2.

Biotech PCRX. Sales are soaring, group rank 38. Earnings are expected to go positive in Dec '14 quarter.

Another therapeutics developer Jazz Pharmaceuticals (JAZZ) also had a pocket pivot yesterday. When JAZZ was smaller and thinner, it had a few "spin-out" days where market makers let the price slip hugely in a matter of minutes or less. Those days seem far behind as JAZZ has been trading normally for close to two years now. Pretax margin 54.4%, ROE 32.1%, group rank 2.

Buyable gap ups:

Pharmaceutical manufacturer of plant-derived medical cannabinoids GW Pharmaceuticals (GWPH) had a buyable gap-up yesterday with an intraday low of 81.12. Group rank 38.

This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.
Copyright ©2024 MoKa Investors, LLC DBA Virtue of Selfish Investing.
All Rights Reserved.
privacy policy